Purchase Order HT001416P0356
- Not listed
- This is a federal contract award to Myriad Genetic Laboratories Inc., a subsidiary of Myriad Genetics Inc., a for-profit organization specializing in personalized medicine and genetic testing services. The contract, awarded by the Department of Veterans Affairs (VA), is for the provision of Prolaris prostate cancer testing services for the VA's Salt Lake City Medical Center. The contract is a Blanket Purchase Agreement (BPA) call with a firm fixed price of $52,954.00 and a performance period...
- This federal contract award is for Myriad Genetic Laboratories Inc., a subsidiary of Myriad Genetics Inc., to provide its Prolaris prostate cancer genetic testing services to the U.S. Department of Veterans Affairs (VA). The contract, with a ceiling value of $6,000.00, is a firm fixed-price delivery order that supports disease risk stratification and treatment planning for veterans served by the VA healthcare system, including the Salt Lake City VA Medical Center. Myriad Genetics Inc. has been...
- This federal contract award was made by the Defense Health Agency (DHA) to Myriad Genetics Inc., a molecular diagnostic company headquartered in Salt Lake City, Utah. The $100,000.00 firm-fixed-price contract is for MYRIAD GENETIC TESTING services, specifically the company's ProLaris testing for prostate cancer. The contract has no set-aside designation, indicating open competition. This award is part of Myriad Genetics Inc.'s ongoing work providing specialized genetic testing services,...
- This is a firm-fixed-price contract awarded by the Medical Command (MEDCOM) of the U.S. Army to Myriad Genetic Laboratories Inc., a subsidiary of Myriad Genetics Inc. The $95,000.00 contract is for the provision of various genetic testing services, with a focus on Prolaris prostate cancer testing. The contract is a Blanket Purchase Agreement (BPA) call, allowing the Department of Veterans Affairs (VA) to efficiently procure Myriad's specialized genetic testing services across multiple regions....
- This $122,672 federal contract was awarded by the Department of Veterans Affairs (VA) to Myriad Genetic Laboratories Inc., a for-profit organization specializing in personalized medicine and genetic testing services. The contract is for the delivery of Prolaris prostate cancer testing services, which analyze genetic information to determine disease progression risks and support clinical treatment decisions. The contract was competitively awarded without a set-aside designation, and is structured...
- This federal contract award is for VARIOUS GENETIC TESTING SERVICES provided by Myriad Genetic Laboratories Inc., a subsidiary of Myriad Genetics Inc., to the U.S. Army Medical Command (MEDCOM). The $95,000.00 Blanket Purchase Agreement (BPA) call contract is for firm fixed-price genetic testing services, with a period of performance through September 30, 2015. The contract does not have a set-aside designation, indicating Myriad Genetic Laboratories competed openly for the award. The primary...
- This contract was awarded by the Department of Defense's Medical Command (MEDCOM) to Myriad Genetic Laboratories Inc., a subsidiary of Myriad Genetics Inc. The contract, valued at $75,124.60, is a Blanket Purchase Agreement (BPA) call for various genetic testing services, with an ultimate completion date of September 30, 2016. The contract is not designated as a set-aside. Myriad Genetic Laboratories, a for-profit organization specializing in personalized medicine and genetic testing services,...
- This federal contract award is for the delivery of Prolaris genetic testing services to the U.S. Department of Veterans Affairs (VA). The prime contractor is Myriad Genetic Laboratories Inc., a subsidiary of Myriad Genetics Inc. that specializes in personalized medicine and genetic testing. The contract was awarded by the VA's Veterans Integrated Service Network 12 (VISN 12) and the VA Salt Lake City Health Care System. It includes two Indefinite Delivery Vehicles (IDVs) - an Indefinite Delivery...
- This federal contract award with ID HT001417A0029|HT001419F0321 was made by the Defense Health Agency (DHA) to Myriad Genetics Inc., a molecular diagnostic company, for Myriad's Prolaris genetic testing services. The $100,000.00 firm-fixed-price contract is for quantitative PCR analysis and reporting to assess prostate cancer aggressiveness and guide treatment approaches. This appears to be a Blanket Purchase Agreement (BPA) call, with Myriad Genetics having been awarded multiple prior BPA calls...
- The U.S. Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 22 (VISN 22), awarded a firm-fixed-price purchase order to Myriad Genetics Inc. for $154,938.00 to provide Prolaris genetic testing services. Prolaris is a molecular diagnostic test that measures gene expression levels to assess prostate cancer aggressiveness. This contract is for the VA Long Beach Healthcare System to utilize Myriad's Prolaris testing capabilities on an as-needed basis from...
This federal contract award to Myriad Genetic Laboratories Inc., a subsidiary of Myriad Genetics Inc., is for a Firm Fixed Price Purchase Order of $7,946.32 to provide MYRIAD GENETIC TESTING services. The contract, awarded by the Defense Health Agency, has an ultimate completion date of February 25, 2017. Myriad Genetic Laboratories Inc. is a for-profit company that specializes in genetic testing and precision medicine services. The primary service provided under this contract is the Prolaris prostate cancer test, which analyzes tumor samples to determine disease progression risk and aid treatment decisions for veterans. Myriad Genetics Inc., the parent company, also holds two significant federal Indefinite Delivery Vehicles (IDVs) with the Department of Veterans Affairs to provide Prolaris testing services, with ceiling values of $149,600 and $74,970 respectively. These IDVs, which do not utilize set-aside designations, allow the VA to efficiently procure Myriad's genetic testing services for prostate cancer screening, diagnosis, and care management of veterans.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | ($92k) | 8/22/22 | |
| Not listed | Not listed | $100.0k | 2/25/16 |